CD44 and neoplasm: CD44 is thought to be involved in the signature of tumor-initiating cells from the analyses of several solid carcinomas such as colon carcinomas, head and neck carcinomas, non-small cell lung cancer, hepatocellular carcinoma, and breast cancer [22], [26]–[29].